Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study

  1. Fernández, M.S.
  2. Sánchez, M.A.
  3. Arribas, F.
  4. Barón-Esquivias, G.
  5. Barrios, V.
  6. Cosin-Sales, J.
  7. Esteve-Pastor, M.A.
  8. Freixa-Pamias, R.
  9. Lekuona, I.
  10. Pérez-Cabeza, A.I.
  11. Ureña, I.
  12. Rodríguez, J.M.V.
  13. Priu, C.R.
  14. Marin, F.
Aldizkaria:
Cardiology Journal

ISSN: 1898-018X,  1897-5593

Argitalpen urtea: 2022

Alea: 29

Zenbakia: 4

Orrialdeak: 601-609

Mota: Artikulua

DOI: 10.5603/CJ.A2022.0044 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus